Clinical Investigation of Hereditary and Acquired Thrombophilic Factors in Patients with Venous and Arterial Thromboembolism

References

• Ageno W, Squizzato A, Garcia D, et al. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost. 2006;32(7):651–658. doi:10.1055/s-2006-951293
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Franchini M, Martinelli I, Mannucci PM. Uncertain thrombophilia markers. Review. Thromb Haemost. 2016;115(01):25–30. doi:10.1160/TH15-06-0478
   PubMedGoogle Scholar
• Garcia-Horton A, Kovacs MJ, Abdulrehman J, et al. Impact of thrombophilia screening on venous thromboembolism management practices. Thromb Res. 2017;149:76–80. doi:10.1016/j.thromres.2016.11.023
   PubMed Web of Science ®Google Scholar
• Colucci G, Tsakiris DA. Thrombophilia screening: universal, selected, or neither? Clin Appl Thromb Hemost. 2017;23(8):893–899. doi:10.1177/1076029616683803
   PubMed Web of Science ®Google Scholar
• Asmis L, Hellstern P. Thrombophilia testing - a systematic review. Clin Lab. 2023;69. doi:10.7754/Clin.Lab.2022.220817
   Web of Science ®Google Scholar
• Kyrle PA, Eichinger S. Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost. 2012;108(6):1061–1064. doi:10.1160/TH12-05-0353
   PubMed Web of Science ®Google Scholar
• Bell KJL, White S, Hassan O. Evaluation of the incremental value of a coronary artery calcium score beyond traditional cardiovascular risk assessment: a systematic review and meta-analysis. JAMA Intern Med. 2022;182(6):634–642. doi:10.1001/jamainternmed.2022.1262
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost. 2015;114(5):885–889. doi:10.1160/TH15-02-0141
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Franchini M. The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism. Expert Rev Hematol. 2014;7(6):757–765. doi:10.1586/17474086.2014.960385
   PubMed Web of Science ®Google Scholar
• Wattanakit K, Lutsey PL, Bell EJ, et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost. 2012;108(3):508–515. doi:10.1160/TH11-10-0726
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Antonella T, Guida A, et al. Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res. 2011;127(3):193–197. doi:10.1016/j.thromres.2010.12.005
   PubMed Web of Science ®Google Scholar
• Gómez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;20:48–49. doi:10.1016/j.jaut.2014.01.006
   Google Scholar
• Lerstad G, Enga KF, Jorde R, et al. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study. Eur J Endocrinol. 2015;173(1):83–90. doi:10.1530/EJE-15-0185
   PubMed Web of Science ®Google Scholar
• Jabbar A, Péingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55. doi:10.1038/nrcardio.2016.174
   PubMed Web of Science ®Google Scholar
• Ashrani AA, Silverstein MD, Lahr BD, et al. Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med. 2009;14(4):339–349. doi:10.1177/1358863X09104222
   PubMed Web of Science ®Google Scholar
• Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42(8):808–820. doi:10.1055/s-0036-1592333
   PubMed Web of Science ®Google Scholar
• Bereczky Z, Gindele R, Speker M, et al. Deficiencies of the natural anticoagulants – novel clinical laboratory aspects of thrombophilia testing. EJIFCC. 2016;27(2):130–146. doi:10.1111/jth.13252
   PubMedGoogle Scholar
• Bereczky Z, Kovács KB, Muszbek L. Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin Chem Lab Med. 2010;48:53–66. doi:10.1515/CCLM.2010.369
   PubMed Web of Science ®Google Scholar
• Efthymiou M, Arachchillage DRJ, Lane PJ, et al. Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome. Thromb Res. 2018;170:60–69. doi:10.1016/j.thromres.2018.08.003
   PubMed Web of Science ®Google Scholar
• Todorova M, Baleva M. Some recent insights into the prothrombogenic mechanisms of antiphospholipid antibodies. Review. Curr Med Chem. 2007;14(7):811–826. doi:10.2174/0929867077800909457
   PubMed Web of Science ®Google Scholar
• Balogh I, Póka R, Pfliegler G, et al. High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary. Thromb Haemost. 1999;81(14):660–661. doi:10.1055/s-0037-1614544
   PubMedGoogle Scholar
• Koster TV, Vandenbroucke JP, Rosendaal FR, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: leiden thrombophilia. Lancet. 1993;342(8886–8887):1503–1506. doi:10.1016/s0140-6736(05)80081-9
   PubMed Web of Science ®Google Scholar
• Van de Water NS, French JK, Lund M, et al. Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol. 2000;36(3):717–722. doi:10.1016/s0735-1097(00)00772-5
   PubMed Web of Science ®Google Scholar
• Rietveld IM, Lijfering WM, Cessie le S, et al. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J Thromb Haemost. 2019;17(1):99–109. doi:10.1111/jth.14343
   PubMed Web of Science ®Google Scholar
• von Martinelli I. Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol. 2005;42(1):49–55. doi:10.1053/j.seminhematol.2004.09.009
   PubMed Web of Science ®Google Scholar
• den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998;80(12):874–877. doi:10.1055/s-0037-1615380
   PubMedGoogle Scholar
• Narcucci R SF, Abbate R, Abbate R, et al. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med. 2007;120(8):728–733. doi:10.1016/j.amjmed.2007.01.029
   PubMed Web of Science ®Google Scholar
• Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49(1):31–62. doi:10.1146/annurev.med.49.1.31
   PubMed Web of Science ®Google Scholar
• Balogh E, Bereczky Z, É K, et al. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. Thromb Res. 2012;129(2):133–138. doi:10.1016/j.thromres.2011.07.001
   PubMed Web of Science ®Google Scholar
• Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, et al. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301(22):2331–2339. doi:10.1001/jama.2009.801
   PubMed Web of Science ®Google Scholar
• Xu J, Li K, Zhou W. Relationship between genetic polymorphism of MTHFR C677T and lower extremities deep venous thrombosis. Hematology. 2019;24(1):108–111. doi:10.1080/10245332.2018.15264402019
   PubMed Web of Science ®Google Scholar
• Santilli F, Davì G, Patrono C. Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective. Vascul Pharmacol. 2016;78:1–9. doi:10.1016/j.vph.2015.06.009
   PubMed Web of Science ®Google Scholar
• Luxembourg B, Henke F, Kirsch-Altena A, et al. Impact of double heterozygosity for Factor V Leiden and Prothrombin G20210A on the thrombotic phenotype. Thromb Res. 2021;200:121–127. doi:10.1016/j.thromres
   PubMed Web of Science ®Google Scholar
• Simone B, De SV, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013;28(8):621–647. doi:10.1007/s10654-013-9825-8
   PubMed Web of Science ®Google Scholar
• Federici EH, Al-Mondhiry H. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A. Thromb Res. 2019;182:75–78. doi:10.1016/j.thromres.2019.07.030
   PubMed Web of Science ®Google Scholar
• Pengo V, Bison E, Denas G, et al. Laboratory diagnostics of antiphospholipid syndrome. Semin Thromb Hemost. 2018;44(05):439–444. doi:10.1055/s-0037-1601331
   PubMedGoogle Scholar
• Kulczynski S. Die Pflanzenassoziationen der Pieninen. Bull Internat Acad Polonaise Sci Lettr. 1927;57–203.
   Google Scholar
• Baglin T, Luddington R, Brow K, et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362(9383):523–526. doi:10.1016/S0140-6736(03)14111-6
   PubMed Web of Science ®Google Scholar
• Bereczky Z, Balogh L, Bagoly Z. Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties. Review. Kardiol Pol. 2019;77(4):419–429. doi:10.33963/KP.14804
   PubMed Web of Science ®Google Scholar
• Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Review. Nat Rev Dis Primers. 2019;5(1):56. doi:10.1038/s41572-019-0106-z
   PubMed Web of Science ®Google Scholar
• Alonso R, Argüeso R, Álvarez-baños P, et al. Familial hypercholesterolemia and lipoprotein(a): two partners in crime? Curr Atheroscler Rep. 2022;24(6):427–434. doi:10.1007/s11883-022-01019-5
   PubMed Web of Science ®Google Scholar
• Lupi-Herrera E, Soto-Lopez ME, Jesus Lugo-Dimas AD, et al. Polymorphisms C677T and A1298C of MTHFR gene: homocysteine levels and prothrombotic biomarkers in coronary and pulmonary thromboembolic disease. Clin Appl Thromb Hemost. 2019:25. doi:10.1177/1076029618780344
   Web of Science ®Google Scholar